Watts Ryan J.
Denali Therapeutics Inc. · President and CEO
Watts Ryan J. is listed in filings as President and CEO at Denali Therapeutics Inc.. This profile follows SEC Form 4 activity through Jan 8, 2026, including sale activity. Recent filings connect the profile to Denali Therapeutics Inc. (DNLI). The current snapshot covers public activity from Aug 22, 2024 to Jan 8, 2026. Reported amounts are shown as $53.8K to $27.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $581k35.2k shares | SellJan 6, 2026 | $16.50 | $23.02 |